TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ATRA

Atara Biotherapeutics Inc

Healthcare · Biotechnology

9.70$ -0.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Atara Biotherapeutics Inc (ATRA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 20 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ATRA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
106 325 264 218 392 343 588 468 376 166 109 20
106 325 261 172 321 273 523 385 295 102 65 12
22 24 48 79 61 74 200 106 93 26 25 8.5
104 320 256 166 310 259 501 371 243 52 42 8.5
1.3 1.0 40 34 1.5 1.3
0.0 0.0 0.0 0.0 0.0 1.6 9.7 11 0.0
0.0 0.3 3.3 44 69 54 51 80 6.3
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
2.9 9.9 10 40 53 52 126 189 250 265 206 59
2.7 9.7 9.7 28 40 37 83 106 79 142 135 15
0.5 0.6 1.6 2.0 2.8 14 12 14 11
0.4 1.4 2.8 15 3.7 8.0 7.1 17 6.9 3.7 4.4 0.1
0.0 0.0 0.0 11
103 315 254 178 339 291 462 280 127 -99 -97 -39
-41 -98 -177 -297 -527 -818 -1,125 -1,465 -1,693 -1,969 -2,055 -2,022
0.2 1.0 1.1 1.2 1.8 2.1 3.0 3.7 4.1 4.2 7.5 13

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?